Search

Search Results

• Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

  Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

  19-06-2023

  568

  PDF: 245

  HTML: 6
• 

  Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome

  Shinta Trilaksmi Dewi, Laily Noor Qomariah, Widya Khairunisa Sarkowi, Monika Puspitasari, Miya Khalidah, Marcella Anggatama, Dwinanda Almira Rizkiani, Kristiana Etnawati, Sri Awalia Febriana

  19-06-2023

  934

  PDF: 471

  HTML: 113
• 

  Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

  Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

  22-05-2023

  678

  PDF: 385

  HTML: 19
• 

  Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

  Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  19-05-2023

  724

  PDF: 367

  HTML: 12
• 

  Delayed diagnosis of adult indolent systemic mastocytosis

  Carsten Sauer Mikkelsen, Andrew Nybo, Kristian Bakke Arvesen, Johan Holk-Poulsen

  17-02-2014

  3090

  PDF: 747

  HTML: 2115

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  1825

  PDF: 564

  HTML: 15
• 

  Erythrodermic psoriasis improved by tildrakizumab

  Giampaolo Trevisan, Lerica Germi, Luigi Naldi

  23-11-2022

  827

  PDF: 415

  HTML: 16
• 

  Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study

  Christa Ky, Brian Swasdibutra, Shaadi Khademi, Sheetal Desai, Vivian Laquer, Sergei A. Grando

  16-03-2015

  2270

  PDF: 971

  HTML: 245
• 

  Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

  Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

  14-03-2022

  2385

  PDF: 472

  HTML: 4

• A microRNA focus on acne

  Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

  02-02-2024

  573

  PDF: 414

  HTML: 30
• 

  Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

  Alhanouf Bin Dakhil, Asem Shadid, Saad Altalhab

  19-05-2023

  3018

  PDF: 633

  APPENDIX 1: 62

  HTML: 9
• 

  Telangiectasia Macularis Eruptiva Perstans: more than skin deep

  Casey E. Watkins, Winston B. Bokor, Stuart Leicht, George Youngberg, Guha Krishnaswamy

  e12

  29-07-2011

  11244

  PDF: 1979

  HTML: 2297
• 

  Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

  Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

  28-12-2021

  3897

  PDF: 509

  APPENDIX: 98

  HTML: 11

• Asian herbal medicine for atopic dermatitis: a systematic review

  Nikko Vanda Limantara, Ronggo Sadono, Suci Widhiati, Retno Danarti

  25-08-2023

  1077

  PDF: 443

  HTML: 13
• 

  Skin reaction to COVID-19 vaccine: a report of 4 cases

  Mariabeatrice Bertolani, Maria Beatrice de Felici del Giudice, Erminia Ridolo, Francesco Pucciarini, Claudio Feliciani, Francesca Satolli

  12-07-2022

  859

  PDF: 360

  HTML: 10
• 

  Atopic dermatitis: a brief review of recent advances in its management

  Sultan Daghafak Alenazi

  23-05-2023

  1642

  PDF: 965

  HTML: 42
• 

  Autoinflammatory diseases: what is behind them and what is new?

  Michele Maalouly, Serena Saade, Mazen Kurban

  29-12-2022

  1465

  PDF: 411

  HTML: 88

• Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

  Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

  11-11-2024

  39

  PDF: 8

  SUPPLEMENTARY: 9

• COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports

  Angelo Massimiliano D'Erme, Cristian Fidanzi, Marco Romanelli, Valentina Dini, Giovanni Bagnoni, Agata Janowska

  24-08-2023

  529

  PDF: 240

  HTML: 16

• Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

  Fitri Kadarsih Banjar, Farida Tabri, Sri Vitayani Muchtar, Mochammad Hatta, Khaeruddin Djawad, Farida Ilyas, Sitti Musafirah, Muhammad Nasrum Massi, Agussalim Bukhari, Andi Alfian Zainuddin

  12-09-2023

  577

  PDF: 299

  HTML: 7
• 

  Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

  Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

  17-03-2022

  892

  PDF: 632

  HTML: 36
• 

  Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

  Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

  25-06-2020

  1123

  PDF: 655

  HTML: 2

• Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

  Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

  11-09-2023

  584

  PDF: 324

  HTML: 8
• 

  Retrospective analysis of endemic melasma patients

  Serkan Demirkan, Özgür Gündüz, Cemile Dayangan Sayan

  16-05-2017

  1381

  PDF: 641

  HTML: 314
• 

  Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

  Uwe Wollina, Andreas Schreiber, Knut Merla, Gunter Haroske

  e57

  13-12-2011

  1683

  PDF: 629

  HTML: 1020